eClinical Tech News

ProKidney Corporation announced that the FDA has confirmed eGFR slope as an acceptable surrogate endpoint for the accelerated approval...

AAVantgarde Bio received FDA clearance for its Investigational New Drug (IND) application for AAVB-039, a gene therapy for Stargardt...

Ascendis Pharma released 3.5-year data from its Phase 3 PaTHway Trial for TransCon PTH (palopegteriparatide) in adults with hypoparathyroidism....

Daré Bioscience announced positive interim safety and efficacy results from its Phase 3 clinical trial of Ovaprene, a hormone-free,...

Health Canada has expanded the approval of Evkeeza (evinacumab) to include children as young as six months old with...

Iovance Biotherapeutics announced positive real-world data for its commercially available melanoma treatment, Amtagvi (lifileucel). A study of 41 patients...

BriaCell Therapeutics Corp. announced positive Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, combined with an immune...

Capricor Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for Deramiocel,...

Rhythm Pharmaceuticals presented data from its clinical programs for acquired hypothalamic obesity at the Endocrine Society’s Annual Meeting (ENDO...

KIF18A, a mitotic kinesin motor protein overexpressed in cancers like ovarian and triple-negative breast cancers, is emerging as a...